ctDNA predicts outcomes in DLBCL [PDF]
Nature Reviews Clinical Oncology, 2018 openaire +2 more sources
Survival after cessation of immunotherapies in melanoma: A systematic review and meta‐analysis
Journal of the European Academy of Dermatology and Venereology, EarlyView.This meta‐analysis on immunotherapy discontinuation in metastatic melanoma demonstrated high progression‐free survival rates at 1 year (86%) and 3 years (71%), and high overall survival rates at 1 year (96%) and 3 years (86%). Elective treatment discontinuation and treatment durations exceeding 1 year were associated with improved survival outcomes ...
Kristine E. Mayer +6 more
wiley +1 more source
Precision medicine in cutaneous melanoma—A comprehensive review
Journal of the European Academy of Dermatology and Venereology, EarlyView.Precision medicine tailors treatment to each patient, beginning with detailed diagnostics. In melanoma, it has advanced considerably: Some methods are in practice and guidelines, while others are commercially available but not routine. This review highlights current and emerging approaches, including molecular profiling, imaging, biomarkers and AI ...
Markus Reitmajer, Lukas Flatz
wiley +1 more source
Painful Realities: Navigating the Complexities of Head and Neck Cancer Pain
Oral Diseases, EarlyView.ABSTRACT Background Head and neck cancer (HNC) and its treatments can cause significant pain, which can profoundly impact patients' quality of life and treatment outcomes. Understanding the full scope of HNC pain is essential for effective management and improved patient care.
Hayden F. Byrd, Zachary A. Kohutek
wiley +1 more source
Cancer Management and ResearchWenlong Qi,1 Lin Tian,2 Jianan Xu,2 Zhenyu Li,2 Tan Wang2 1Changchun University of Traditional Chinese Medicine, Changchun, Jilin, 130000, People’s Republic of China; 2Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun,
Qi W, Tian L, Xu J, Li Z, Wang T
doaj
Circulating tumor DNA (ctDNA) in advanced non-small cell lung cancer (NSCLC) from HIV-infected patients is associated to shorter overall survival (OS): Results from phase II trial (IFCT-1001 CHIVA) [PDF]
, 2018 Marie Wislez +18 more
openalex +1 more source
Genetics of mCRPC tracked in ctDNA [PDF]
Nature Reviews Clinical Oncology, 2016 openaire +4 more sources
Nanotechnology‐Enabled Blood Test for Oral Epithelial Disorders Management: A Proof‐of‐Concept Study
Oral Diseases, EarlyView.ABSTRACT Objective To address the limitations and complexities associated with tissue biopsy, emerging nanotechnology methods show promise in enhancing the detection and management of oral squamous cell carcinoma and oral potential malignant disorders.
Erica Quagliarini +9 more
wiley +1 more source
Recent advancements in artificial intelligence‐powered cancer prediction from oral microbiome
Periodontology 2000, EarlyView.Abstract Oral cancer is a major global health burden, ranking sixth in prevalence, with oral squamous cell carcinoma (OSCC) being the most common type. Importantly, OSCC is often diagnosed at late stages, underscoring the need for innovative methods for early detection.
Negin Soghli +4 more
wiley +1 more source
CSF-ctDNA SMSEQ Analysis to Tailor the Treatment of a Patient with Brain Metastases: A Case Report [PDF]
, 2018 Wen‐Tsung Huang +6 more
openalex +1 more source